Citadel Advisors
REPL icon

Citadel Advisors’s Replimune Group REPL Stock Holding History

Citadel Advisors’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.36M Buy
178,100
+76,500
+75% +$585K ﹤0.01% 6942
2025
Q4 		$988K Sell
101,600
-288,200
-74% -$2.45M ﹤0.01% 7416
2025
Q3 		$1.63M Buy
389,800
+237,800
+156% +$1.52M ﹤0.01% 6487
2025
Q2 		$1.41M Buy
152,000
+89,400
+143% +$780K ﹤0.01% 6383
2025
Q1 		$610K Buy
62,600
+59,200
+1,741% +$733K ﹤0.01% 8038
2024
Q4 		$41.2K Sell
3,400
-9,300
-73% -$113K ﹤0.01% 12590
2024
Q3 		$139K Buy
12,700
+8,600
+210% +$87.4K ﹤0.01% 10663
2024
Q2 		$36.9K Sell
4,100
-23,700
-85% -$165K ﹤0.01% 12067
2024
Q1 		$227K Sell
27,800
-44,800
-62% -$367K ﹤0.01% 10065
2023
Q4 		$612K Sell
72,600
-38,700
-35% -$449K ﹤0.01% 7662
2023
Q3 		$1.9M Buy
111,300
+84,100
+309% +$1.65M ﹤0.01% 5313
2023
Q2 		$632K Buy
27,200
+24,400
+871% +$477K ﹤0.01% 7429
2023
Q1 		$49.4K Buy
2,800
+1,800
+180% +$42.8K ﹤0.01% 12160
2022
Q4 		$27.2K Buy
+1,000
New +$20.8K ﹤0.01% 12852
2021
Q3 		– Sell
-33,100
Closed -$1.27M – 14510
2021
Q2 		$1.27M Sell
33,100
-39,700
-55% -$1.36M ﹤0.01% 7719
2021
Q1 		$2.22M Buy
72,800
+38,600
+113% +$1.45M ﹤0.01% 6137
2020
Q4 		$1.3M Buy
+34,200
New +$1.43M ﹤0.01% 6227

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citadel Advisors's REPL Position: Q1 2026 in Review

Citadel Advisors increased its Replimune Group (REPL) stake by 152% in Q1 2026, buying an estimated $1.84M and bringing the position to 398,729 shares worth $3.05M. The position accounts for ﹤0.01% of the portfolio, ranked #5228.

Citadel Advisors first reported a position in REPL in Q3 2018 and has held it in 31 quarters since. The position peaked at $44.4M in Q4 2020. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • Citadel Advisors held 398,729 shares of Replimune Group worth $3.05M as of Q1 2026.
  • Citadel Advisors bought 240,370 Replimune Group shares in Q1 2026, an estimated $1.84M.
  • Replimune Group made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #5228 holding.
  • Citadel Advisors first reported a position in Replimune Group in Q3 2018 and has held it in 31 quarters since.
  • Citadel Advisors's Replimune Group position peaked at $44.4M in Q4 2020.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.